Vincent A. Blomen

5.4k total citations · 2 hit papers
31 papers, 3.4k citations indexed

About

Vincent A. Blomen is a scholar working on Molecular Biology, Infectious Diseases and Cell Biology. According to data from OpenAlex, Vincent A. Blomen has authored 31 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Infectious Diseases and 7 papers in Cell Biology. Recurrent topics in Vincent A. Blomen's work include CRISPR and Genetic Engineering (7 papers), Viral gastroenteritis research and epidemiology (5 papers) and Genomics and Chromatin Dynamics (5 papers). Vincent A. Blomen is often cited by papers focused on CRISPR and Genetic Engineering (7 papers), Viral gastroenteritis research and epidemiology (5 papers) and Genomics and Chromatin Dynamics (5 papers). Vincent A. Blomen collaborates with scholars based in Netherlands, United States and Austria. Vincent A. Blomen's co-authors include Thijn R. Brummelkamp, Jan E. Carette, Lucas T. Jae, Joppe Nieuwenhuis, J. Boonstra, Jacqueline Staring, René H. Medema, Giulio Superti‐Furga, Matthijs Raaben and Robin H. van der Weide and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Vincent A. Blomen

31 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene essentiality and synthetic lethality in haploid human cells

2015 559 citations Vincent A. Blomen, Peter Májek et al. Science profile →
The Cohesin Release Factor WAPL Restricts Chromatin Loop Extension

2017 519 citations Judith H.I. Haarhuis, Robin H. van der Weide et al. Cell profile →

Peers

Countries citing papers authored by Vincent A. Blomen

Since Specialization

Citations

This map shows the geographic impact of Vincent A. Blomen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent A. Blomen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent A. Blomen more than expected).

Fields of papers citing papers by Vincent A. Blomen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent A. Blomen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent A. Blomen. The network helps show where Vincent A. Blomen may publish in the future.

Co-authorship network of co-authors of Vincent A. Blomen

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent A. Blomen. A scholar is included among the top collaborators of Vincent A. Blomen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent A. Blomen. Vincent A. Blomen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PLA2G15 is a BMP hydrolase and its targeting ameliorates lysosomal disease 2025 ·Nature ·Kwamina Nyame, Jian Xiong, (unknown), Arthur P.H. de Jong, I. Peña, (unknown), Thijn R. Brummelkamp, Guido Hartmann, Sebastian Nijman, Matthijs Raaben, Judith Simcox, Vincent A. Blomen, Monther Abu-Remaileh	4
2	MND1 enables homologous recombination in somatic cells primarily outside the context of replication 2023 ·Molecular Oncology ·(unknown), (unknown), (unknown), Femke M. Feringa, Bram van den Broek, (unknown), (unknown), Michaël Schubert, Vincent A. Blomen, Thijn R. Brummelkamp, Lenno Krenning, René H. Medema	8
3	A Mediator-cohesin axis controls heterochromatin domain formation 2022 ·Nature Communications ·Judith H.I. Haarhuis, Robin H. van der Weide, Vincent A. Blomen, Koen D. Flach, Hans Teunissen, (unknown), Thijn R. Brummelkamp, Benjamin D. Rowland, Elzo de Wit	24
4	E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes 2020 ·Proceedings of the National Academy of Sciences ·Stephanie L. Sarbanes, Vincent A. Blomen, (unknown), Søren Heissel, Joseph M. Luna, Thijn R. Brummelkamp, Erik Falck-Pedersen, Hans-Heinrich Hoffmann, Charles M. Rice	10
5	Haploid genetic screens identify genetic vulnerabilities to microtubule‐targeting agents 2018 ·Molecular Oncology ·Nora M. Gerhards, Vincent A. Blomen, Merve Mutlu, Joppe Nieuwenhuis, (unknown), Charlotte Guyader, Jos Jonkers, Thijn R. Brummelkamp, Sven Rottenberg	10
6	KREMEN1 Is a Host Entry Receptor for a Major Group of Enteroviruses 2018 ·Cell Host & Microbe ·Jacqueline Staring, Lisa G. van den Hengel, Matthijs Raaben, Vincent A. Blomen, Jan E. Carette, Thijn R. Brummelkamp	64
7	BUB1 Is Essential for the Viability of Human Cells in which the Spindle Assembly Checkpoint Is Compromised 2018 ·Cell Reports ·Jonne A. Raaijmakers, Roy G. H. P. van Heesbeen, Vincent A. Blomen, Louise M.E. Janssen, (unknown), Thijn R. Brummelkamp, René H. Medema	63
8	Loss of Kif18A Results in Spindle Assembly Checkpoint Activation at Microtubule-Attached Kinetochores 2018 ·Current Biology ·Louise M.E. Janssen, (unknown), Vincent A. Blomen, Thijn R. Brummelkamp, René H. Medema, Jonne A. Raaijmakers	28
9	Vasohibins encode tubulin detyrosinating activity 2017 ·Science ·Joppe Nieuwenhuis, Athanassios Adamopoulos, Onno B. Bleijerveld, Abdelghani Mazouzi, Elmer Stickel, Patrick H. N. Celie, Maarten Altelaar, Puck Knipscheer, Anastassis Perrakis, Vincent A. Blomen, Thijn R. Brummelkamp	178
10	NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry 2017 ·Cell Host & Microbe ·Matthijs Raaben, Lucas T. Jae, Andrew S. Herbert, Ana I. Kuehne, Sarah H. Stubbs, Yi‐ying Chou, Vincent A. Blomen, Tomas Kirchhausen, John M. Dye, Thijn R. Brummelkamp, Sean P. J. Whelan	91
11	The Cohesin Release Factor WAPL Restricts Chromatin Loop Extension breakdown → 2017 ·Cell ·Judith H.I. Haarhuis, Robin H. van der Weide, Vincent A. Blomen, J. Omar Yáñez-Cuna, Mario Amendola, Marjon S. van Ruiten, Peter H.L. Krijger, Hans Teunissen, René H. Medema, Bas van Steensel, Thijn R. Brummelkamp, Elzo de Wit, Benjamin D. Rowland	519
12	Enterovirus D68 receptor requirements unveiled by haploid genetics 2016 ·Proceedings of the National Academy of Sciences ·Jim Baggen, Hendrik Jan Thibaut, Jacqueline Staring, Lucas T. Jae, Yue Liu, Hongbo Guo, (unknown), (unknown), Arno L. W. van Vliet, Vincent A. Blomen, Pier Paul Overduin, Ju Sheng, Cornelis A. M. de Haan, Erik de Vries, Adam Meijer, Michael G. Rossmann, Thijn R. Brummelkamp, Frank J. M. van Kuppeveld	77
13	Gene essentiality and synthetic lethality in haploid human cells breakdown → 2015 ·Science ·Vincent A. Blomen, Peter Májek, Lucas T. Jae, Johannes W. Bigenzahn, Joppe Nieuwenhuis, Jacqueline Staring, Roberto Sacco, Ferdy R. van Diemen, Nadine Olk, Alexey Stukalov, Caleb Marceau, Hans Janßen, Jan E. Carette, Keiryn L. Bennett, Jacques Colinge, Giulio Superti‐Furga, Thijn R. Brummelkamp	559
14	Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer 2015 ·Cancer Research ·Ruud H. Wijdeven, Baoxu Pang, Sabina Y. van der Zanden, Xiaohang Qiao, Vincent A. Blomen, Marlous Hoogstraat, Esther H. Lips, Lennert Janssen, Lodewyk F.A. Wessels, Thijn R. Brummelkamp, Jacques Neefjes	56
15	Subunit composition of VRAC channels determines substrate specificity and cellular resistance to P t‐based anti‐cancer drugs 2015 ·The EMBO Journal ·Rosa Planells‐Cases, (unknown), Charlotte Guyader, Nora M. Gerhards, Florian Ullrich, (unknown), Aslι Küçükosmanoğlu, Guotai Xu, (unknown), S. Momsen Reincke, Tobias Stauber, Vincent A. Blomen, Daniël J. Vis, Lodewyk F.A. Wessels, Thijn R. Brummelkamp, Piet Borst, Sven Rottenberg, Thomas J. Jentsch	209
16	The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity 2014 ·Nature Chemical Biology ·Georg E. Winter, Branka Radic-Sarikas, Cristina Mayor‐Ruiz, Vincent A. Blomen, Claudia Jessen‐Trefzer, Richard K. Kandasamy, K. Huber, Manuela Gridling, Doris Chen, Thorsten Klampfl, Róbert Královics, Stefan Kubicek, Óscar Fernández-Capetillo, Thijn R. Brummelkamp, Giulio Superti‐Furga	128
17	Cathepsin-mediated Necrosis Controls the Adaptive Immune Response by Th2 (T helper type 2)-associated Adjuvants 2013 ·Journal of Biological Chemistry ·Lee S. Jacobson, Heriberto Lima, Michael F. Goldberg, Vasilena Gocheva, Vladislav Tsiperson, Fayyaz S. Sutterwala, Johanna A. Joyce, Bianca V. Gapp, Vincent A. Blomen, Kartik Chandran, Thijn R. Brummelkamp, Felipe Diaz‐Griffero, Jürgen Brojatsch	55
18	Global gene disruption in human cells to assign genes to phenotypes by deep sequencing 2011 ·Nature Biotechnology ·Jan E. Carette, Carla P. Guimarães, Irene Wuethrich, Vincent A. Blomen, Malini Varadarajan, Chong Sun, George W. Bell, Bingbing Yuan, Markus K. Muellner, Sebastian Nijman, Hidde L. Ploegh, Thijn R. Brummelkamp	173
19	Generation of iPSCs from cultured human malignant cells 2010 ·Blood ·Jan E. Carette, Jan Pruszak, Malini Varadarajan, Vincent A. Blomen, Sumita Gokhale, Fernando D. Camargo, Marius Wernig, Rudolf Jaenisch, Thijn R. Brummelkamp	171
20	Stable transmission of reversible modifications: maintenance of epigenetic information through the cell cycle 2010 ·Cellular and Molecular Life Sciences ·Vincent A. Blomen, J. Boonstra	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact